The world produces 2.5 quintillion (billion billion) bytes every day. Within this ever-expanding deluge of data lies clues that businesses can use to guide their decision making. The one, not-so-minor problem is that many of these insights (often the most valuable ones) are spread across a myriad of unconnected sources.
Conquering the external data challenge is particularly relevant to the pharmaceutical industry where data-backed insights can focus development efforts and mitigate the risks and not-insubstantial costs of drug innovation
The scale of these analytics efforts would have been unthinkable just 10 years ago, but with Signals Analytics, pharmaceutical companies are able to connect and organize unstructured data from thousands of scientific and market sources in order to: